Hitachimycin
File:Hitachimycin.png | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C29H35NO5 |
Molar mass | 477.592 g/mol |
WikiDoc Resources for Hitachimycin |
Articles |
---|
Most recent articles on Hitachimycin Most cited articles on Hitachimycin |
Media |
Powerpoint slides on Hitachimycin |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Hitachimycin at Clinical Trials.gov Clinical Trials on Hitachimycin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Hitachimycin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Hitachimycin Discussion groups on Hitachimycin Patient Handouts on Hitachimycin Directions to Hospitals Treating Hitachimycin Risk calculators and risk factors for Hitachimycin
|
Healthcare Provider Resources |
Causes & Risk Factors for Hitachimycin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Hitachimycin, also known as stubomycin, is a cyclic polypeptide produced by Streptomyces that acts as an antibiotic. It exhibits cytotoxic activity against mammalian cells, Gram-positive bacteria, yeast, and fungi, as well as hemolytic activity; this is mediated by changes at the cell membrane and subsequent lysis.[1] Owing to its cytotoxic activity against mammalian cells and tumors, it was first proposed as a antitumor antibiotic.[2]
As of 2007, it has not been used in a clinical setting.
References
- ↑ Komiyama K, Edanami K, Tanoh A, Yamamoto H, Umezawa I (1983). "Studies on the biological activity of stubomycin". J. Antibiot. 36 (3): 301–11. PMID 6833150.
- ↑ Umezawa I, Takeshima H, Komiyama K, Koh Y, Yamamoto H, Kawaguchi M (1981). "A new antitumor antibiotic, stubomycin". J. Antibiot. 34 (3): 259–65. PMID 7275806.
- Pages with script errors
- CS1 maint: Multiple names: authors list
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Antibiotics